QNCX
#4730
Quince Therapeutics, Inc. - Common Stock
17.2 5 USD
-0.02%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-1.65%
Variación mensual
+1754.84%
Variación en los últimos 6 meses
+471.19%
Cambio anual
+853.04%
Cierres anteriores
17.5 4
Open
17.2 5
Mínimo
17.2 5
High
17.2 5
Volumen
2
Financials
- Market Capitalization 14.06 M
- Employee 38
- Founded 2012
- CEO N/A
- Website www.quincetx.com
- Headquarter California, United States
- FIGI BBG00BTK1DT8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.99
Relación precio/flujo de caja
7 036.67
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 4724 |  PASG Passage Bio, Inc. - Common Stock | 4.46 USD | -2.41% | -4.50% | -21.62% | -49.55% | 14.31 M USD | ||
| 4729 |  GTBP GT Biopharma, Inc. - Common Stock | 0.39 USD | -9.30% | -17.02% | -18.75% | -81.78% | 14.06 M USD | ||
| 4740 |  BLRX BioLineRx Ltd - American Depositary Shares | 3.10 USD | +0.32% | -1.59% | -8.82% | +10.32% | 13.49 M USD | ||
| 4744 |  INTS Intensity Therapeutics, Inc. - Common Stock | 4.92 USD | +2.93% | +7.89% | +34.43% | +1390.91% | 13.30 M USD |